{"id":"W2338830431","doi":"10.1016/j.ahj.2016.04.010","title":"NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank","year":2016,"lang":"en","type":"review","venue":"American Heart Journal","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Apixaban; Dabigatran; Rivaroxaban; Edoxaban; Dosing; Atrial fibrillation; Vitamin K antagonist; Intensive care medicine; Warfarin; Pharmacology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08115754,0.001391004,0.008995498,0.003030561,0.0009312322,0.006354655,0.004294165,0.007917308,0.004068654],"category_scores_gemma":[0.08926908,0.001224017,0.006495023,0.002799419,0.002192357,0.009018089,0.002716258,0.01144004,0.0006886094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005433495,"about_ca_system_score_gemma":0.02128086,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005829763,"about_ca_topic_score_gemma":0.02042852,"domain_scores_codex":[0.9843426,0.006784182,0.003655109,0.001180818,0.003505471,0.0005318266],"domain_scores_gemma":[0.8391969,0.1322861,0.009240721,0.002095091,0.01564379,0.001537454],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002114607,0.0002290389,0.001037223,0.116029,0.007091896,0.0001615939,0.0004595579,0.0005389493,0.0005659261,0.01491015,0.07616051,0.7807015],"study_design_scores_gemma":[0.003734443,0.001487768,0.004116079,0.4812387,0.02865246,0.0005700042,0.001372828,0.001679661,0.0006239529,0.03395867,0.4423255,0.0002399005],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002718626,0.9800056,0.0003866438,0.01748115,0.001352108,0.00008318118,0.00005848393,0.00001073126,0.0003502104],"genre_scores_gemma":[0.006838347,0.9642628,0.003960864,0.02044818,0.003590761,0.0002774674,0.0001012165,0.00001427059,0.0005061497],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.08115754,"threshold_uncertainty_score":0.4292072,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1873838281922353,"score_gpt":0.48640400553374,"score_spread":0.2990201773415048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}